Combining UK Biobank genetics and MRI imaging data to identify genetic factors associated with higher body fat % but lower risk of diabetes.
|
|
- Malcolm Reynolds
- 5 years ago
- Views:
Transcription
1 Combining genetics and MRI imaging data to identify genetic factors associated with higher body fat % but lower risk of diabetes. Hanieh Yaghootkar Diabetes UK RD Lawrence Fellow 21 June 2018 meeting - London
2 Some people develop diabetes at lower BMIs and some people are healthy at higher BMIs which is partly genetically defined. Percentage of individuals Type 2 diabetic patients (N=12,333; mean age 61) Non-diabetic individuals (N=370,112mean age 57) Data from Body mass index (BMI)
3 Some people develop diabetes at lower BMIs and some people are healthy at higher BMIs which is partly genetically defined. Percentage of individuals Type 2 diabetic patients (N=12,333; mean age 61) Non-diabetic individuals (N=370,112mean age 57) Data from Body mass index (BMI)
4 Genetic factors associated with favourable adiposity will help understand mechanisms that delay or protect individuals from type 2 diabetes. Type 2 diabetes Odds ratio Body fat % Type 2 diabetes Odds ratio Body fat % Unfavourable adiposity Favourable adiposity FTO variant PPARG variant Data from
5 We characterized 14 genetic variants associated with favourable adiposity. Body fat % (n = 500,000) Published genome-wide association analysis Negative correlation Positive correlation Body fat % (n= 70,000) Lu et al. Nature communications (2016). Adiponectin (N=29,400) Dastani et al. PLoS Genet (2012). SHBG (N=21,800) Coviello et al. PLoS Genet (2012). HDL-C (N=99,900) Teslovich et al. Nature (2010). Fasting insulin (N=51,800) Manning et al. Nature genetics (2012). Triglycerides (N=96,600) Teslovich et al. Nature (2010). Alanine transaminase (N=55,500) Chambers et al. Nature genetics (2011). [DNAH10] VEGFA [] C6orf223 AEBP2 [] PDE3A [DNAH10] LYPLAL1 [] SLC30A10 VEGFA [] C6orf223 [FAM13A] AEBP2 [] PDE3A [PEPD] LYPLAL1 [] SLC30A10 CITED2 [] [FAM13A] NYAP2 [] IRS1 [PEPD] CITED2 [] GRB14 [] COBLL1 NYAP2 [] IRS1 [PPARG] GRB14 [] COBLL1 ANKRD55 [] MAP3K1 [PPARG] [MAFF] ANKRD55 [] MAP3K1 KLF14 [] MKLN1 [MAFF] TRIB1 [] [DNAH10] KLF14 [] MKLN1 [TNFSF12 TNFSF13] VEGFA [] C6orf223 TRIB1 [] [TNFSF12 TNFSF13] [ACO2] AEBP2 [] PDE3A [ACO2] [RORA] LYPLAL1 [] SLC30A10 [RORA] PCDH17 [] DIAPH3 [FAM13A] [PEPD] PCDH17 [] DIAPH3 [TCF7L2] [TCF7L2] [POM121C] CITED2 [] [POM121C] [TET1] NYAP2 [] IRS1 [TET1] [KIAA1755] GRB14 [] COBLL1 [KIAA1755] [PPARG] ZBTB7C [] CTIF ZBTB7C [] CTIF ANKRD55 [] MAP3K1 MYCN [] FAM49A MYCN [] FAM49A [MAFF] [ZZEF1] [ZZEF1] KLF14 [] MKLN1 PRMT6 [] NTNG1 TRIB1 [] [PPP1R21] [TNFSF12 TNFSF13] [FTO] [ACO2] [ACMSD] [RORA] Associated with higher body fat % but better metabolic profile Associated with higher body fat % and adverse metabolic profile
6 Favourable adiposity variants together were associated with higher adiposity but lower risk of type 2 diabetes, heart disease and hypertension Body fat % N = 443,000 Type 2 diabetes (Odds ratio) 14,371 cases, 428,017 controls Heart disease (Odds ratio) Systolic blood pressure (mmhg) Diastolic blood pressure (mmhg) 37,741 cases, 318,892 controls N = 450,075 N = 450,075 Effects Per 5+ alleles x x x x x10-24 Data from
7 The favourable adiposity effect is not driven by altered body shape in men detectable by waist-to-hip ratio Women 207,126 Men 175,776 Waist circumference Hip circumference Waist circumference Hip circumference Data from
8 We investigated the associations between the favourable adiposity variants and MRI/CT scan measures of abdominal adipose tissue. Visceral and subcutaneous fat (N = 27,766) Liver fat (N = 9,210) Image from: West J. et al. Feasibility of MR-Based Body Composition Analysis in Large Scale Population Studies. PloS One, 2016 Image from: Wilman HR. et al. Characterisation of liver fat in the cohort. PloS One, 2017 (N = 5,045) The Netherlands Epidemiology of Obesity Study () (N = 2,236) Tübingen Family Study for Type-2 Diabetes (TÜF) (N = 833) (N = 1,320) Published GWAS* (N = 18,332) (N = 5,045) The Netherlands Epidemiology of Obesity Study () (N = 1,821) Tübingen Family Study for Type-2 Diabetes (TÜF) (N = 911) (N = 1,433) *Chu A. et al. Multiethnic genome-wide meta-analysis of ectopic fat depots identifies loci associated with adipocyte development and differentiation. Nature Genetics, 2016
9 Favourable adiposity variants together were associated with higher subcutaneous fat but lower liver fat. Subcutaneous fat (Litres) All Chu et al Visceral fat (Litres) All Chu et al All Liver fat (%) Women Chu et al Women Chu et al Women Men Chu et al Men Chu et al Men
10 Favourable adiposity alleles have similar effects in South Asians comparing to Europeans, but are less frequent in South Asians Body fat % BMI (kg/m 2 ) Type 2 diabetes (Odds ratio) Heart disease (Odds ratio) Effects Per 5+ alleles Average number of alleles 10.5 vs 11.6; P< ,000 Europeans 10,203 South Asians Genetic score of favourable adiposity Data from
11 The identification of favourable adiposity alleles locate genes that may be targets for novel insulin-sensitizing agents. Thiazolidinediones (PPAR-γ agonists) redistributes fat away from liver towards an expanded subcutaneous depot
12 Acknowledgements The Genetics of Complex Traits team at Exeter: Analysis of MRI image data of abdominal & liver fat: : Jimmy Bell, Alex Blakemore and Andrianos Yiorkas Robin Beaumont Tim Frayling Rachel Freathy James Harrison Yingjie Ji Sam Jones Anna Murray study: Francesca Frau, Louise Thomas, Karla V. Allebrandt, Ewan Pearson study: Dennis Mook-Kanamori, Renée de Mutsert, Kate Ruth Seth Sharp William Thompson Marcus Tuke Jessica Tyrrell Mike Weedon Andy Wood TÜF study: Norbert Stefan, Harald Staiger
13 The identification of favourable adiposity alleles locate genes that may be targets for novel insulin-sensitizing agents. Thiazolidinediones (PPAR-γ agonists) redistributes fat away from liver towards an expanded subcutaneous depot TRIB1 adipose tissue mass and lipolysis. VEGF-A maintains healthy expansion of adipose tissue and protects from lipotoxicity. CITED2 is required for optimal PPARγ activation. FAM13A is in the insulin signaling cascade. IRS1, CCDC92 and DNAH10 are associated with adipogenesis, lipid accumulation and adipocyte differentiation. KLF14 is a master regulator of gene expression in adipose tissue and associated with adipocyte cell size. MAP3K1 regulates expression of IRS1. LYPLAL1 maintains triglycerides metabolism.
Carrying more favourable adiposity gene7c factors is associated with higher adiposity but lower ectopic fat and lower risk of type 2 diabetes.
Carrying more favourable adiposity gene7c factors is associated with higher adiposity but lower ectopic fat and lower risk of type 2 diabetes. Hanieh Yaghootkar 15 March 2018 Diabetes UK - London Who has
More informationThis is an author's accepted manuscript of an article published in
WestminsterResearch http://www.westminster.ac.uk/westminsterresearch Genome-wide and abdominal MRI-imaging data provides evidence that a genetically determined favourable adiposity phenotype is characterized
More informationFat distribution matters!
Fat distribution matters! Findings from the first 6,000 UKBB participants Tommy Johansson, CEO AMRA Medical June 20 th 2018 Overweight and Obesity Definitions Today BMI* = Weight/Height 2 (82 kg/1,82 2
More informationEffects of Obesity Related Genetic Variations on Visceral and Subcutaneous Fat Distribution in a Chinese Population
Effects of Obesity Related Genetic Variations on Visceral and Subcutaneous Fat Distribution in a Chinese Population Tao Wang #, Xiaojing Ma #, Danfeng Peng, Rong Zhang, Xue Sun, Miao Chen, Jing Yan, Shiyun
More informationObesity, Metabolic Syndrome, and Diabetes: Making the Connections
Obesity, Metabolic Syndrome, and Diabetes: Making the Connections Alka M. Kanaya, M.D. Associate Professor of Medicine & Epi/Biostats University of California, San Francisco February 26, 21 Roadmap 1.
More informationFTO gene variants are strongly associated with type 2 diabetes in South Asian Indians
Diabetologia (2009) 52:247 252 DOI 10.1007/s00125-008-1186-6 SHORT COMMUNICATION FTO gene variants are strongly associated with type 2 diabetes in South Asian Indians C. S. Yajnik & C. S. Janipalli & S.
More informationUMHS-PUHSC JOINT INSTITUTE
Role of Visceral Adiposity in the Pathogenesis of Non-Alcoholic Fatty Liver Disease in Lean versus Obese Patients: A Comparative Study between Patients at UMHS versus PUHSC Lai WEI and Anna LOK W Zhang,
More informationAUTONOMIC FUNCTION IS A HIGH PRIORITY
AUTONOMIC FUNCTION IS A HIGH PRIORITY 1 Bladder-Bowel-AD Tetraplegia Sexual function Walking Bladder-Bowel-AD Paraplegia Sexual function Walking 0 10 20 30 40 50 Percentage of respondents an ailment not
More informationRoadmap. Diabetes and the Metabolic Syndrome in the Asian Population. Asian. subgroups 8.9. in U.S. (% of total
Diabetes and the Metabolic Syndrome in the Asian Population Alka Kanaya, MD Associate Professor of Medicine, UCSF Feb 26, 2010 Roadmap 1. Diabetes in Asian Americans Prevalence in the U.S. Risk factors
More informationKnow Your Number Aggregate Report Single Analysis Compared to National Averages
Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics
More informationLetter to the Editor. Association of TCF7L2 and GCG Gene Variants with Insulin Secretion, Insulin Resistance, and Obesity in New-onset Diabetes *
814 Biomed Environ Sci, 2016; 29(11): 814-817 Letter to the Editor Association of TCF7L2 and GCG Gene Variants with Insulin Secretion, Insulin Resistance, and Obesity in New-onset Diabetes * ZHANG Lu 1,^,
More informationValue and challenges of combining large cohorts
Value and challenges of combining large cohorts Rory Collins UK Biobank Principal Investigator BHF Professor of Medicine & Epidemiology Nuffield Department of Population Health Richard Doll Building University
More informationAssociation between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese
Diabetes Care Publish Ahead of Print, published online June 12, 2008 Raised Blood Pressure and Dysglycemia Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese Bernard My Cheung,
More informationHSN301 REVISION NOTES TOPIC 1 METABOLIC SYNDROME
HSN301 REVISION NOTES TOPIC 1 METABOLIC SYNDROME What does the term Metabolic Syndrome describe? Metabolic syndrome describes a cluster of cardio-metabolic conditions that increase one's risk of developing
More informationChanges and clinical significance of serum vaspin levels in patients with type 2 diabetes
Changes and clinical significance of serum vaspin levels in patients with type 2 diabetes L. Yang*, S.J. Chen*, G.Y. Yuan, D. Wang and J.J. Chen Department of Endocrinology, Affiliated Hospital of Jiangsu
More informationSupplemental Table 1 Age and gender-specific cut-points used for MHO.
Supplemental Table 1 Age and gender-specific cut-points used for MHO. Age SBP (mmhg) DBP (mmhg) HDL-C (mmol/l) TG (mmol/l) FG (mmol/l) Boys 6-11 90th * 90th * 1.03 1.24 5.6 12 121 76 1.13 1.44 5.6 13 123
More informationUnderstanding phenotypes of prediabetes: essential to influencing progression to type 2 diabetes. October 2015; SAGLB.DIA
Understanding phenotypes of prediabetes: essential to influencing progression to type 2 diabetes October 2015; SAGLB.DIA.15.10.0821 Acknowledgement The content of this slide deck summarizes the key points
More informationCardiometabolic Side Effects of Risperidone in Children with Autism
Cardiometabolic Side Effects of Risperidone in Children with Autism Susan J. Boorin, MSN, PMHNP-BC PhD Candidate Yale School of Nursing 1 This speaker has no conflicts of interest to disclose. 2 Boorin
More informationKnow Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up
Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up... Study Population: 340... Total Population: 500... Time Window of Baseline: 09/01/13 to 12/20/13... Time Window of Follow-up:
More informationLarge-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways
Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways Through genome-wide association meta-analyses of up to 133,010
More information3/25/2010. Age-adjusted incidence rates for coronary heart disease according to body mass index and waist circumference tertiles
Outline Relationships among Regional Adiposity, Physical Activity, and CVD Risk Factors: Preliminary Results from Two Epidemiologic Studies Molly Conroy, MD, MPH Obesity Journal Club February 18, 2010
More informationMetabolic Syndrome in Asians
Metabolic Syndrome in Asians Alka Kanaya, MD Asst. Professor of Medicine, UCSF Asian CV Symposium, November 17, 2007 The Metabolic Syndrome Also known as: Syndrome X Insulin Resistance Syndrome The Deadly
More informationFat Accumulation and Obesity-related Cardiovascular Risk Factors in Middle-aged Japanese Men and Women
ORIGINAL ARTICLE Fat Accumulation and Obesity-related Cardiovascular Risk Factors in Middle-aged Japanese Men and Women Miwa Ryo 1, Tohru Funahashi 1, Tadashi Nakamura 1, Shinji Kihara 1, Kazuaki Kotani
More informationAssociation of serum adipose triglyceride lipase levels with obesity and diabetes
Association of serum adipose triglyceride lipase levels with obesity and diabetes L. Yang 1 *, S.J. Chen 1 *, G.Y. Yuan 1, L.B. Zhou 2, D. Wang 1, X.Z. Wang 1 and J.J. Chen 1 1 Department of Endocrinology,
More information3/20/2011. Body Mass Index (kg/[m 2 ]) Age at Issue (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Mokdad A.H.
U.S. Adults: 1988 Nineteen states with 10-14% 14% Prevalence of Obesity (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Metabolic John P. Cello, MD Professor of Medicine and Surgery, University of California,
More informationTesamorelin Clinical Data Overview Jean-Claude Mamputu, PhD Senior Medical Advisor, Theratechnologies
Tesamorelin Clinical Data Overview Jean-Claude Mamputu, PhD Senior Medical Advisor, Theratechnologies Copyright 2016. All Rights Reserved. Property of Theratechnologies Inc. Mechanism of Action of Tesamorelin
More informationEndocrine Disrupters as Obesogens
Endocrine Disrupters as Obesogens Is the environment making us fat? Bruce Blumberg, Ph.D. Department of Developmental and Cell Biology Department of Pharmaceutical Sciences Developmental Biology Center
More informationHSN301 Diet and Disease Entire Note Summary
Topic 1: Metabolic Syndrome Learning Objectives: 1. Define obesity 2. Factors causing obesity 3. Obesity as a risk factor for metabolic syndrome 4. The pathogenesis of metabolic syndrome 5. Treatment of
More informationFAT. It s Not All That! A Closer Look at the Two Main Types of Fat in Our Bodies: Visceral and Subcutaneous Fat
Mary-Kate Perrone Capstone Seminar July 14, 2007 Draft #2 Fat Stats FAT. It s Not All That! A Closer Look at the Two Main Types of Fat in Our Bodies: Visceral and Subcutaneous Fat According to the 2003-2004
More informationDuring the hyperinsulinemic-euglycemic clamp [1], a priming dose of human insulin (Novolin,
ESM Methods Hyperinsulinemic-euglycemic clamp procedure During the hyperinsulinemic-euglycemic clamp [1], a priming dose of human insulin (Novolin, Clayton, NC) was followed by a constant rate (60 mu m
More informationCommon Variants of FTO Are Associated with Childhood Obesity in a Cross-Sectional Study of 3,126 Urban Indian Children
Common Variants of FTO Are Associated with Childhood Obesity in a Cross-Sectional Study of 3,126 Urban Indian Children Om Prakash Dwivedi 1., Rubina Tabassum 1., Ganesh Chauhan 1, Saurabh Ghosh 2, Raman
More informationDiabetes and Obesity Sex- and Gender-differences!
Oskar Kokoschka 1908 Das Mädchen Li und ich Diabetes and Obesity Sex- and Gender-differences! Alexandra Kautzky Willer IGM, Berlin 2015 Global Diabetes-Epidemic Increase (%) in age-standardised diabetes
More informationEffects of growth hormone secretagogue receptor agonist and antagonist in nonobese type 2 diabetic MKR mice
Effects of growth hormone secretagogue receptor agonist and antagonist in nonobese type 2 diabetic MKR mice Rasha Mosa (MBCHC, M.D, PhD candidate) School of Biomedical Sciences University of Queensland
More informationThe omics approach in measuring the double burden of malnutrition
IAEA Headquarter, Vienna, Austria, 3-5 October 2017 Joint IAEA-WHO-UNICEF workshop on analysis of biological pathways to better understand the double burden of malnutrition and to inform action planning
More informationI have nothing to disclose.
I have nothing to disclose. Epicardial vs Pericardial Fat? Implications of this Question Thomas H Marwick MBBS, PhD, MPH Menzies Research Institute, Hobart, Australia Epicardial and pericardial fat 1.
More informationUnderstanding the metabolic syndrome
Understanding the metabolic syndrome Understanding the metabolic system Metabolic syndrome is the clustering together of a number of risk factors for heart disease, stroke and diabetes. Having one of these
More informationBody Composition in NASH Clinical Trials
Body Composition in NASH Clinical Trials Jonathan Riek, PhD VP, Musculoskeletal and Metabolic Imaging, BioTel Research Olof Dahlqvist Leinhard, PhD Chief Scientific Officer & Co-Founder, AMRA 2/26/2018
More informationIn The Name Of God. In The Name Of. EMRI Modeling Group
In The Name Of God In The Name Of God EMRI Modeling Group Cells work together in functionally related groups called tissues Types of tissues: Epithelial lining and covering Connective support Muscle movement
More informationObesity and the Metabolic Syndrome in Developing Countries: Focus on South Asians
Obesity and the Metabolic Syndrome in Developing Countries: Focus on South Asians Anoop Misra Developing countries, particularly South Asian countries, are witnessing a rapid increase in type 2 diabetes
More informationMetabolic Syndrome: Bad for the Heart and Bad for the Brain? Kristine Yaffe, MD Univ. of California, San Francisco
Metabolic Syndrome: Bad for the Heart and Bad for the Brain? Kristine Yaffe, MD Univ. of California, San Francisco Why would diabetes and obesity be bad for the brain? Insulin receptors in brain Insulin
More informationClinical Study Rs Variant of the Fat Mass and Obesity-Associated Gene and Trunk Obesity in Adolescents
Obesity Volume 2011, Article ID 186368, 4 pages doi:10.1155/2011/186368 Clinical Study Rs9939609 Variant of the Fat Mass and Obesity-Associated Gene and Trunk Obesity in Adolescents Harald Mangge, 1 Wilfried
More informationFigure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution
Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein
More informationThe role of physical activity in the prevention and management of hypertension and obesity
The 1 st World Congress on Controversies in Obesity, Diabetes and Hypertension (CODHy) Berlin, October 26-29 2005 The role of physical activity in the prevention and management of hypertension and obesity
More informationEffects of environment and genetic interactions on chronic metabolic diseases
22 1 2010 1 Chinese Bulletin of Life Sciences Vol. 22, No. 1 Jan., 2010 1004-0374(2010)01-0001-06 ( 200031) 2 2 20 2 2 2 R151; R589; R587.1; R363.16 A Effects of environment and genetic interactions on
More informationTable S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416).
Table S1. Characteristics associated with frequency of nut (full entire sample; Nn=4,416). Daily nut Nn= 212 Weekly nut Nn= 487 Monthly nut Nn= 1,276 Infrequent or never nut Nn= 2,441 Sex; n (%) men 52
More informationPongamorn Bunnag, MD Boonsong Ongphiphadhanakul, MD. Mahidol University
Roles oesof Fetuin-A in Hypertension Pongamorn Bunnag, MD Boonsong Ongphiphadhanakul, MD Ramathibodi Hospital Mahidol University Fetuin-A (Alpha-2-HS-glycoprotein) Multi-functional protein secreted by
More informationMetabolic Syndrome.
www.bmiweightloss.com.au What is the metabolic syndrome? The was first described in 1988 by Gerald Reavson It was originally described as the clustering of four conditions These conditions when present
More informationPsoriasis and the metabolic syndrome
Psoriasis and the metabolic syndrome MD, PhD James G. Krueger 1 Inflammation as a foundation of metabolic dysregulation and cardiovascular disease risk Diseases of systemic immune activation and inflammation,
More informationORIGINAL ARTICLE AMBULATORY BLOOD PRESSURE IN OBESITY. Introduction. Patients and Methods
Vol. 2, Issue 1, pages 31-36 ORIGINAL ARTICLE AMBULATORY BLOOD PRESSURE IN OBESITY By Alejandro de la Sierra, MD Luis M. Ruilope, MD Hypertension Units, Hospital Clinico, Barcelona & Hospital 12 de Octubre,
More informationDr. Claude Bouchard. John W. Barton, Sr. Chair in Genetics and Nutrition Louisiana State University
Dr. Claude Bouchard John W. Barton, Sr. Chair in Genetics and Nutrition Louisiana State University 2014 SEC Symposium A GENETIC PREDISPOSITION IS AMONG THE DRIVERS OF THE OBESITY EPIDEMIC: IMPLICATIONS
More informationMetabolic Syndrome: An overview. Kevin Niswender MD, PhD Vanderbilt University School of Medicine
Metabolic Syndrome: An overview. Kevin Niswender MD, PhD Vanderbilt University School of Medicine Setting the scene GB, 43 yo AA man followed for hypothyroidism returns on LT4 125 mcg/d and has a TSH=1.1
More information902 Biomed Environ Sci, 2014; 27(11):
902 Biomed Environ Sci, 2014; 27(11): 902-906 Letter to the Editor Curcuminoids Target Decreasing Serum Adipocyte-fatty Acid Binding Protein Levels in Their Glucose-lowering Effect in Patients with Type
More informationObesity mediated hypertension and renal dysfunction
Obesity mediated hypertension and renal dysfunction Gergely Bodor Marion Hervouet Nicky Honnef Mariarosaria Malgadi Julie Robert Tutor: Pr Alina Parvu Objectives 1. Introduction 2. Renal structural and
More informationSupplementary Online Content
Supplementary Online Content Larsen JR, Vedtofte L, Jakobsen MSL, et al. Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia
More informationThe Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk
The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine
More informationCarol Davila University of Medicine and Pharmacy, Bucharest, Romania
Mædica - a Journal of Clinical Medicine MAEDICA a Journal of Clinical Medicine 2016; 11(5): 32-37 ORIGINAL PAPER Changes in Fasting Plasma Glucose, HbA1c and Triglycerides Are Related to Changes in Body
More informationMetabolic Syndrome: Why Should We Look For It?
021-CardioCase 29/05/06 15:04 Page 21 Metabolic Syndrome: Why Should We Look For It? Dafna Rippel, MD, MHA and Andrew Ignaszewski, MD, FRCPC CardioCase presentation Andy s fatigue Andy, 47, comes to you
More informationTHE FIRST NINE MONTHS AND CHILDHOOD OBESITY. Deborah A Lawlor MRC Integrative Epidemiology Unit
THE FIRST NINE MONTHS AND CHILDHOOD OBESITY Deborah A Lawlor MRC Integrative Epidemiology Unit d.a.lawlor@bristol.ac.uk Sample size (N of children)
More informationdnadiet GENOTYPE REPORT Sharon Richey Patient Name: DNA ZA Date of Birth: Sample Number: Referring Practitioner: Private
dnadiet GENOTYPE REPORT Patient Name: Date of Birth: Sample Number: Sharon Richey 1972-07-23 DNA 003 264 ZA Referring Practitioner: Private Date Reported: 2014-01-27 HOW TO READ THIS REPORT This genetic
More informationTHE INFLUENCE OF WEIGHT LOSS ON ARTERIAL STIFFNESS IN OBESE AND OVERWEIGHT SUBJECTS
2012 ILEX PUBLISHING HOUSE, Bucharest, Roumania http://www.jrdiabet.ro Rom J Diabetes Nutr Metab Dis. 19(4):353-360 doi: 10.2478/v10255-012-0041-1 THE INFLUENCE OF WEIGHT LOSS ON ARTERIAL STIFFNESS IN
More informationSupplemental Table 1. Components of MDS and AHEI
Supplemental Table 1. Components of MDS and AHEI MDS AHEI Vegetable Fruit SSB & fruit juice Nut Legume Whole grain Fish Red meat MUFA/SAT ratio EPA & DHA PUFA Trans-fat Alcohol Sodium MDS: Mediterranean-style
More informationObesity in the pathogenesis of chronic disease
Portoroz October 16th 2013 Obesity in the pathogenesis of chronic disease Rocco Barazzoni University of Trieste Department of Medical, Surgical and Health Sciences Obesity Trends* Among U.S. Adults BRFSS,
More informationObesity and Breast Cancer in a Multiethnic Population. Gertraud Maskarinec, MD, PhD University of Hawaii Cancer Center, Honolulu, HI
Obesity and Breast Cancer in a Multiethnic Population Gertraud Maskarinec, MD, PhD University of Hawaii Cancer Center, Honolulu, HI Background Breast cancer incidence remains lower in many Asian than Western
More informationOver the past year, the capacity to perform
BRIEF REPORT Adiposity-Related Heterogeneity in Patterns of Type 2 Diabetes Susceptibility Observed in Genome-Wide Association Data Nicholas J. Timpson, 1,2 Cecilia M. Lindgren, 1,3 Michael N. Weedon,
More informationA study of waist hip ratio in identifying cardiovascular risk factors at Government Dharmapuri College Hospital
Original Research Article A study of waist hip ratio in identifying cardiovascular risk factors at Government Dharmapuri College Hospital M. Arivumani * Assistant Professor of General Medicine, Government
More informationType 2 Diabetes in Native Hawaiians according to Admixture: The Multiethnic Cohort
Type 2 Diabetes in Native Hawaiians according to Admixture: The Multiethnic Cohort Gertraud Maskarinec, Yukiko Morimoto, Simone Jacobs, Andrew Grandinetti, Marjorie Mau, Laurence N. Kolonel Prevalence
More informationSUPPLEMENTARY DATA. 1. Characteristics of individual studies
1. Characteristics of individual studies 1.1. RISC (Relationship between Insulin Sensitivity and Cardiovascular disease) The RISC study is based on unrelated individuals of European descent, aged 30 60
More informationFTO Polymorphisms Are Associated with Obesity But Not with Diabetes in East Asian Populations: A Meta analysis
BIOMEDICAL AND ENVIRONMENTAL SCIENCES 22, 449 457 (2009) www.besjournal.com FTO Polymorphisms Are Associated with Obesity But Not with Diabetes in East Asian Populations: A Meta analysis BO XI #, + AND
More informationAnthropometry: What Can We Measure & What Does It Mean?
Anthropometry: What Can We Measure & What Does It Mean? Anne McTiernan, MD, PhD Fred Hutchinson Cancer Research Center Seattle, Washington, U.S.A. I have no conflicts to disclose. Anthropometry in Human
More informationRelationship of Waist Circumference and Lipid Profile in Children
International Journal of Biomedical Science and Engineering 2015; 3(3): 44-48 Published online May 28, 2015 (http://www.sciencepublishinggroup.com/j/ijbse) doi: 10.11648/j.ijbse.20150303.12 ISSN: 2376-7227
More informationMetabolic syndrome. Metabolic syndrome and prediabetes appear to be the same disorder, just diagnosed by a different set of biomarkers.
Metabolic syndrome Metabolic syndrome is a disorder of energy utilization and storage, diagnosed by a co-occurrence of three out of five of the following medical conditions: abdominal (central) obesity,
More informationWAIST-HEIGHT RATIO : A NEW OBESITY INDEX FOR FILIPINOS?
WAIST-HEIGHT RATIO : A NEW OBESITY INDEX FOR FILIPINOS? Consuelo L. Orense, MSPH, Charmaine A. Duante, RMT, MS Epid.(PH), Ermelita N. Bautista, MPH and Lilibeth P. Dasco, MSAN ABSTRACT The study aimed
More informationgenotype report optimal diet for life Name: 1990/01/28 Date of Birth: DNA ZA Sample Number: Private Referring Practitioner:
optimal diet for life genotype report Name: Date of Birth: Sample Number: Referring Practitioner: --- --- 1990/01/28 DNA 000 000 ZA Private Date Reported: 2015/04/14 Page No. 2 of 18 How to read this report
More informationSupplemental Information. Weight Gain and Impaired Glucose. Metabolism in Women Are Predicted. by Inefficient Subcutaneous Fat Cell Lipolysis
Cell Metabolism, Volume 28 Supplemental Information Weight Gain and Impaired Glucose Metabolism in Women Are Predicted by Inefficient Subcutaneous Fat Cell Lipolysis Peter Arner, Daniel P. Andersson, Jesper
More informationPCSK1, MC4R, FTO, MAP2K5, GNPDA2
/, 2017, Vol. 8, (No. 55), pp: 93593-93607 The role of established East Asian obesity-related loci on pediatric leptin levels highlights a neuronal influence on body weight regulation in Chinese children
More information--Manuscript Draft-- Fibroblast Growth Factor; FGF21; body fat distribution; BMI; body mass index; blood pressure; carbohydrate intake; genetics.
Cell Reports A common allele in FGF21 associated with sugar intake is associated with altered body shape, lower total body-fat percentage and higher blood pressure --Manuscript Draft-- Manuscript Number:
More informationOBESITY IN PRIMARY CARE
OBESITY IN PRIMARY CARE Obesity- definition Is a chronic disease In ICD 10 E66 Overweight and obesity are defined as abnormal or excessive fat accumulation that may impair health. Obesity is a leading
More informationSalt, soft drinks & obesity Dr. Feng He
Salt, soft drinks & obesity Dr. Feng He Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, UK f.he@qmul.ac.uk BP Salt CVD Obesity
More informationT2D risk phenotype after recent GDM. Supplemental Materials and Methods. Methodology of IVGTT/euglycemic hyperinsulinemic clamp
Supplemental Materials and Methods Methodology of IVGTT/euglycemic hyperinsulinemic clamp A combined IVGTT/euglycemic hyperinsulinemic clamp was performed in subgroups of study participants following the
More informationNephropathy in Type 1 Diabetes: Can One Identity the Patients at Risk?
Nephropathy in Type 1 Diabetes: Can One Identity the Patients at Risk? Pierre Lefèbvre University of Liège, Belgium Cuba, November 2007 Nephropathy in Type 1 Diabetes It has been known for years that the
More informationShiftwork and cardiometabolic outcomes. Dr Anil Adisesh
Shiftwork and cardiometabolic outcomes Dr Anil Adisesh 1 FACULTY/PRESENTER DISCLOSURE Faculty: Dr Anil Adisesh Relationships with commercial interests: - None 2 Aims 1) Participants will be able to describe
More informationASSeSSing the risk of fatal cardiovascular disease
ASSeSSing the risk of fatal cardiovascular disease «Systematic Cerebrovascular and coronary Risk Evaluation» think total vascular risk Assess the risk Set the targets Act to get to goal revised; aupril
More informationHeritability and genetic correlations explained by common SNPs for MetS traits. Shashaank Vattikuti, Juen Guo and Carson Chow LBM/NIDDK
Heritability and genetic correlations explained by common SNPs for MetS traits Shashaank Vattikuti, Juen Guo and Carson Chow LBM/NIDDK The Genomewide Association Study. Manolio TA. N Engl J Med 2010;363:166-176.
More informationUnderstanding Clinical Assessment Using The Edmonton Obesity Staging System
Understanding Clinical Assessment Using The Edmonton Obesity Staging System Arya M Sharma, MD. PhD, FRCPC Research Chair for Obesity Research & Management University of Alberta Medical Director Alberta
More informationTHEORIES ON OBESITY AND TYPE 2 DIABETES MELLITUS: PREDICTORS OF SHORT-TERM WEIGHT LOSS AND DISEASE PREVENTION IN ELEMENTARY SCHOOL CHILDREN
THEORIES ON OBESITY AND TYPE 2 DIABETES MELLITUS: PREDICTORS OF SHORT-TERM WEIGHT LOSS AND DISEASE PREVENTION IN ELEMENTARY SCHOOL CHILDREN Item Type text; Electronic Thesis Authors LANG, JESSICA CHRISTINE
More informationAdipose Tissue Dysfunction and Diabetic Cardiovascular Disease
Adipose Tissue Dysfunction and Diabetic Cardiovascular Disease Xin-Liang Ma, MD, PhD Thomas Jefferson University Philadelphia, PA USA CVD As The #1 Causes of Death In USA Male Female Heart Disease and
More informationHypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents
Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Stella Stabouli Ass. Professor Pediatrics 1 st Department of Pediatrics Hippocratio Hospital Evaluation of
More informationAn update on the obesity epidemics in CKD and in ESRD. Does it really matter?
EURECA-m 2011 An update on cutting-edge Cardiovascular and Renal Medicine themes. An update on the obesity epidemics in CKD and in ESRD. Does it really matter? Francesca Mallamaci BMI>30 25 Ireland 20
More informationNicolucci C. (1), Rossi S. (2), Catapane M. (1), Introduction:
Bisphenol A and Nicolucci C. (1), Rossi S. (2), Catapane M. (1), (1) Dept. Experimental Medicine, Second University of (2) Institute of Genetic and Biophysics, CNR, Naples (3) Dept. of Pediatrics 'F. Fede',
More informationSu Yon Jung 1*, Eric M. Sobel 2, Jeanette C. Papp 2 and Zuo-Feng Zhang 3
Jung et al. BMC Cancer (2017) 17:290 DOI 10.1186/s12885-017-3284-7 RESEARCH ARTICLE Open Access Effect of genetic variants and traits related to glucose metabolism and their interaction with obesity on
More informationNAFLD AND TYPE 2 DIABETES
NAFLD AND TYPE 2 DIABETES Sonia Caprio, MD STOPNASH Symposium on the Origin and Pathways of Nonalcoholic Steatohepatitis Washington 7, 215 Global Projection of Diabetes Hossain P et al. N Engl J Med 27;356:213
More informationTest5, Here is Your My5 to Health Profile with Metabolic Syndrome Insight
Test5, Here is Your My5 to Health Profile with Metabolic Syndrome Insight Quest, Quest Diagnostics, the associated logo, and all associated Quest Diagnostics marks are the registered trademarks of Quest
More informationTreadmill Workstations: A Worksite Physical Activity Intervention
Treadmill Workstations: A Worksite Physical Activity Intervention Dinesh John, Ph.D. 1,2 Dixie L. Thompson, Ph.D., FACSM 1 Hollie Raynor 1, Ph.D. 1 Kenneth M. Bielak. M.D. 1 David R. Bassett, Ph.D., FACSM
More informationLecture 7 Body Composition Lecture 7 1. What is Body Composition? 2. Healthy Body Weight 3. Body Fat Distribution 4. What Affects Weight Gain?
Lecture 7 Body Composition 1 Lecture 7 1. What is Body Composition? 2. Healthy Body Weight 3. Body Fat Distribution 4. What Affects Weight Gain? 2 1 Body Composition Relative amounts of fat and fat-free
More informationPREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS
PREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS Mehmet Emre Atabek,MD,PhD Necmettin Erbakan University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Endocrinology and
More informationWestminsterResearch
WestminsterResearch http://www.westminster.ac.uk/research/westminsterresearch Circulating Pancreatic Polypeptide Concentrations Predict Visceral and Liver Fat Content Amir H. Sam Michelle L. Sleeth E.
More informationMetabolic Syndrome: What s in a name?
Commentary Metabolic Syndrome: What s in a name? Deborah P. Wubben, MD, MPH; Alexandra K. Adams, MD, PhD Abstract The term metabolic syndrome has recently become en vogue. But is the definition realistic,
More informationMetabolic Syndrome. DOPE amines COGS 163
Metabolic Syndrome DOPE amines COGS 163 Overview - M etabolic Syndrome - General definition and criteria - Importance of diagnosis - Glucose Homeostasis - Type 2 Diabetes Mellitus - Insulin Resistance
More informationThe State of Play of Diabetes Indicators
The State of Play of Diabetes Indicators South Australian and National Information Catherine Chittleborough Janet Grant Anne Taylor April 2003 Diabetes Clearing House Population Research and Outcome Studies
More informationChanges in Cardiotrophin-1 and Fibroblast Growth Factor-21 with Weight Loss. Robert Lawrence Bowers
Changes in Cardiotrophin-1 and Fibroblast Growth Factor-21 with Weight Loss by Robert Lawrence Bowers A dissertation submitted to the Graduate Faculty of Auburn University in partial fulfillment of the
More information